Hypertension and increased CVD risk - size of the prize (part 2)

Loading

Hypertension and increased CVD risk - size of the prize (part 2)

07 Oct 2019
CLINICAL THEATRE
Part 2 - The NHS Long Term Plan identifies cardiovascular disease (CVD) as a clinical priority and the single biggest condition where lives can be saved by the NHS over the next 10 years. Evidence suggests that statin therapy to reduce cholesterol by 1mmol/L in people with a 10 year risk of CVD over 10% will reduced the risk of CVD events by 20-24% Reducing blood pressure by 5mmHg in adults with hypertension will reduce CVD events by 10%. This session will focus on the opportunities to reduce mortality and morbidity associated with high blood pressure and those at increased risk of CVD.
Speakers
Mr Paul Wright, Lead Cardiac Pharmacist - Barts Health NHS Trust

SHOW COUNTDOWN

In Association With

  • Pfizer


 

Supported By

  • AIM
  • Bayer
  • Cegedimrx
  • Day-Lewis-Pharmacy
  • GPC
  • NHS-Digital
  • NHS-England
  • NPA
  • PCPA
  • PDA
  • PSNC


 

Education Partners

  • AIM
  • BD-Rowa
  • Centred-Solutions
  • CPPE
  • Day-Lewis
  • ECG
  • Flarin
  • GAMA
  • gsk
  • Health-Education-England
  • Invatech
  • JUUL
  • MSD
  • Natures-Bounty
  • NHS-Digital
  • NPA
  • Numark
  • OMRON
  • Parkinsons
  • PDA
  • PSNC
  • Real-World-Analytics
  • RPS
  • RxAdvisor
  • Scope
  • Seqirus
  • Soar-Beyond
  • Velresco
  • WELL


 

Sponsored By

  • Alphega
  • Bollore
  • CD
  • CPPE
  • emis
  • gsk
  • NHS-Digital
  • NHS-England
  • NPA
  • Numark
  • Pfizer
  • RBforHealth


 

Charity Partners

  • Arthritis
  • Pancreatic
  • Parkinsons
  • Pharmacist


 

Official Media Partner

  • CIG


 

Official Publications

  • Independent
  • P3Pharmacy
  • Pharmacy
  • Pharmacy-Network
  • TM


 

Digital Media Partner

  • CD


 

Natural Education Partner

  • NPB


 

Media Partners

  • Guidelines
  • Pharmacy-Business
  • Pharmacy-In-Focus
  • PharmacyTalk
  • PharmData
  • PM
  • ScottishPharmacist